Adenosine-dopamine interactions in the brain

Agnati, 1983, Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8in vitro, Biosci. Rep., 3, 1101, 10.1007/BF01120202 Agnati, 1983, Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites, Acta physiol. scand., 118, 79, 10.1111/j.1748-1716.1983.tb07244.x Albin, 1989, The functional anatomy of basal ganglia disorders, Trends Neurosci., 12, 366, 10.1016/0166-2236(89)90074-X Alexander, 1990, Functional architecture and basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci., 13, 266, 10.1016/0166-2236(90)90107-L Alexander, 1989, The cellular localization of adenosine receptors in rat neostriatum, Neuroscience, 28, 645, 10.1016/0306-4522(89)90011-0 Andén, 1966, Functional role of the nigrostriatal dopamine neurons, Acta Pharmacol. Toxicol., 24, 263, 10.1111/j.1600-0773.1966.tb00389.x Barraco, 1984, Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat, Neurosci. Lett., 48, 139, 10.1016/0304-3940(84)90009-0 Boissier, 1965, Action de la caffeine sur la motilitée spontanée de la souris, Arch. int. Pharmacodyn. Thér, 158, 212 Boyson, 1986, Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain, J. Neurosci., 6, 3177, 10.1523/JNEUROSCI.06-11-03177.1986 Brené, 1990, Expression of dopamine D2 receptor and choline acetyl transferase mRNA in the dopamine deafferented rat caudate-putamen, Expl. Brain Res., 83, 96, 10.1007/BF00232197 Bristol, 1988, The search for purine and ribose-substituted adenosine analogs with potential clinical application, 17 Brodie, 1987, Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action, Brain Res., 415, 323, 10.1016/0006-8993(87)90214-9 Brown, 1991, Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation, Psychopharmacology, 103, 78, 10.1007/BF02244078 Bruns, 1986, Characterization of the A2 adenosine receptor labeled by3H-NECA in rat striatal membranes, Molec. Pharmac., 29, 331 Bruns, 1988, Adenosine antagonists as pharmacological tools, 39 Bunzow, 1988, Cloning and expression of a rat D2 dopamine receptor cDNA, Nature, 336, 783, 10.1038/336783a0 Casas, 1989, Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway, Neuropharmacology, 28, 407, 10.1016/0028-3908(89)90037-3 Casas, 1989, Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors, Pharmac. Biochem. Behav., 29, 609, 10.1016/0091-3057(89)90396-1 Chowdhury, 1991, Presynaptic adenosine A2 and N-methyl-spd-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes, J. Neurochem., 56, 1783, 10.1111/j.1471-4159.1991.tb02081.x Coffin, 1986, Effects of selected analogs of adenosine on schedule controlled behaviour in rats, Neuropharmacology, 25, 1141, 10.1016/0028-3908(86)90162-0 Corrodi, 1973, Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons, J. Pharm. Pharmacol, 25, 409, 10.1111/j.2042-7158.1973.tb10037.x Daly, 1983, Subclasses of adenosine receptors in the central nervous system. Interactions with caffeine and related methylxanthines, Cell Molec. Neurobiol., 1, 69, 10.1007/BF00734999 Daly, 1991, Analogs of caffeine and theophylline: activity as antagonists at adenosine receptors, 119 DeLong, 1990, Primate models of movement disorders of basal ganglia origin, Trends Neurosci., 13, 281, 10.1016/0166-2236(90)90110-V Dunwiddie, 1985, The physiological role of adenosine in the central nervous system, Int. Rev. Neurobiol., 27, 63, 10.1016/S0074-7742(08)60556-5 Durcan, 1989, NECA-induced hypomotility in mice: evidence for a predominantly central site of action, Pharmac. Biochem. Behav., 32, 487, 10.1016/0091-3057(89)90185-8 Durcan, 1989, Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice, Eur. J. Pharmac., 168, 285, 10.1016/0014-2999(89)90789-9 Durcan, 1990, Prospective role for adenosine and adenosinergic systems in psychiatric disorders (Editorial), Psychol. Med., 20, 475, 10.1017/S0033291700016986 Elazar, 1991, Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor, J. Neurochem., 56, 75, 10.1111/j.1471-4159.1991.tb02564.x Erinoff, 1986, Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels and response to caffeine, Pharmac. Biochem. Behav., 24, 1039, 10.1016/0091-3057(86)90453-3 von Euler, 1987, Neurotensin reduces the affinity of D2 receptors in rat striatal membranes, Acta physiol. scand., 131, 625, 10.1111/j.1748-1716.1987.tb08285.x von Euler, 1991, A trypsin inhibitor-like peptide PEC-60 reduces the affinity of dopamine D2 agonist binding sites in rat neostriatal membranes, Eur. J. Pharmac. molec. Pharmac. Sec., 207, 365, 10.1016/0922-4106(91)90013-8 Fastbom, 1987, The distribution of adenosine A1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals, Neuroscience, 22, 813, 10.1016/0306-4522(87)92961-7 Ferré, 1990, Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes, Eur. J. Pharmac., 179, 295, 10.1016/0014-2999(90)90168-6 Ferré, 1991, Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit a D-2 mediated behaviour in short-term reserpinized mice, Eur. J. Pharmac., 192, 30 Ferré, 1991, Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice, Eur. J. Pharmac., 192, 36, 10.1016/0014-2999(91)90065-X Ferré, 1991, Stimulation of adenosine A2 receptors induces catalepsy, Neurosci. Lett., 130, 162, 10.1016/0304-3940(91)90387-9 Ferré, 1991, Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes, 88, 7237 Ferré, 1992, Dopamine denervation leads to an increase in the membrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum, Brain Res., 594, 124, 10.1016/0006-8993(92)91036-E Fredholm, 1976, Effect of some phosphodiesterase inhibitors on central dopamine mechanisms, Eur. J. Pharmac., 38, 31, 10.1016/0014-2999(76)90198-9 Fredholm, 1977, Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine, Med. Biol., 55, 262 Fredholm, 1979, Modulation of neurotransmission by purine nucleotides, Biochem. Pharmac., 29, 1635, 10.1016/0006-2952(80)90117-3 Fredholm, 1980, Are methylxanthine effects due to antagonism of endogenous adenosine?, Trends pharmac. Sci., 1, 129, 10.1016/0165-6147(79)90046-4 Fredholm, 1983, On the mechanisms by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat, Pharmac. Biochem. Behav., 19, 535, 10.1016/0091-3057(83)90131-4 Fredholm, 1985, Adenosine and central catecholamine neurotransmission, 91 Fredholm, 1988, Formation and actions of adenosine in the rat hippocampus, with special reference to the interactions with classical transmitters, 437 Freissmuth, 1992, Interactions of the bovine brain A1-adenosine receptor and recombinant G protein α-subunits. Selectivity for rGiα-3, J. biol. Chem., 266, 17,778, 10.1016/S0021-9258(18)55194-2 Fuxe, 1974, Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with I-dopa and dopamine agonists, Med. Biol., 52, 48 Fuxe, 1981, Modulation by cholecystokinins of3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites, Acta physiol. scand., 113, 567, 10.1111/j.1748-1716.1981.tb06942.x Fuxe, 1984, I-Glutamate reduces the affinity of 3H-N-propylnorapomorphine binding sites in striatal membranes, Eur. J. Pharmac., 100, 127, 10.1016/0014-2999(84)90326-1 Fuxe, 1985, Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses, Med. Res. Rev., 5, 441, 10.1002/med.2610050404 Fuxe, 1990, Modulation of dopamine D1 and D2 transmission lines in the central nervous system, Vol. 1, 203 Gerfen, 1990, D1 and D2 dopamine receptor-regulated gene expression of strionigral and striopallidal neurons, Science, 250, 1429, 10.1126/science.2147780 Glowa, 1984, Behavioural effects of caffeine, N6-(L-phenylisopropyl) adenosine and their combination in the squirrel monkey, J. Pharmac. Exp. Ther., 216, 484 Greden, 1974, Anxiety or caffeinism: a diagnostic dilemma, Am. J. Psychiat., 131, 1089 Green, 1982, Modulation of striatal dopaminergic function by local injection of 5′-N-ethylcarboxamide adenosine, Science, 218, 58, 10.1126/science.7123218 Griebel, 1991, Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX, Psychopharmacology, 103, 541, 10.1007/BF02244256 Griebel, 1991, Behavioural effects of selective A2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice, Neuropharmac. Neurotoxicol., 2, 139 Griffiths, 1988, Reinforcing effects of caffeine in humans, J. Pharmac. exp. Ther., 246, 21 Griffiths, 1988, Reinforcing properties of caffeine: studies in humans and laboratory animals, Pharmac. Biochem. Behav., 29, 419, 10.1016/0091-3057(88)90180-3 Harms, 1979, Effects of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum, Neuropharmacology, 18, 577, 10.1016/0028-3908(79)90107-2 Heffner, 1989, Comparison of the behavioural effects of adenosine agonists and dopamine antagonists in mice, Psychopharmacology, 98, 31, 10.1007/BF00442002 Herrera-Marschitz, 1988, Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses, Psychopharmacology, 94, 38, 10.1007/BF00735878 Hutchison, 1989, CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity, J. Pharmac. exp. Ther., 251, 47 Jarvis, 1989, Autoradiographic characterization of high affinity adenosine A2 receptors in the rat brain, Brain Res., 484, 111, 10.1016/0006-8993(89)90353-3 Jarvis, 1989, [3H]CGS 21680, a selective A2 adenosine agonist directly labels A2 receptors in rat brain, J. Pharmac. exp. Ther., 251, 888 Jarvis, 1989, Direct autoradiographic localization of adenosine A2 receptors in the rat brain, Eur. J. Pharmac., 168, 243, 10.1016/0014-2999(89)90571-2 Jarvis, 1990, Adenosine in central nervous system function, 324 Josselyn, 1991, Behavioural effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine, Pharmac. Biochem. Behav., 39, 97, 10.1016/0091-3057(91)90403-O Lehmann, 1983, The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?, Neuroscience, 10, 1105, 10.1016/0306-4522(83)90102-1 Le Moine, 1990, Dopamine receptor gene expression by enkephalin neurons in rat forebrain, 87, 230 Le Moine, 1990, D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum, Neurosci. Lett., 117, 248, 10.1016/0304-3940(90)90671-U Le Moine, 1991, Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene, 88, 4205 Levant, 1988, The psychobiology of neurotensin, Vol. 8, 232 Libert, 1989, Selective amplification and cloning of four new members of the G-protein-coupled receptor family, Science, 244, 569, 10.1126/science.2541503 Libert, 1991, Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor, Genomics, 11, 225, 10.1016/0888-7543(91)90125-X Lupica, 1990, Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum, J. Pharmac. exp. Ther., 252, 1134 Maenhaut, 1990, RDC8 codes for an adenosine A2 receptor with physiological constitutive activity, Biochem. biophys. Res. Commun., 173, 1169, 10.1016/S0006-291X(05)80909-X Magistretti, 1986, Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism, J. Neurosci., 6, 2558, 10.1523/JNEUROSCI.06-09-02558.1986 Marsden, 1982, Basal ganglia disease, Lancet, 2, 1141, 10.1016/S0140-6736(82)92797-0 Martin, 1984, Huntington's disease: new approaches to an old problem, Neurology, Minneap., 34, 1059, 10.1212/WNL.34.8.1059 Martinez-Mir, 1991, Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease, Neuroscience, 42, 697, 10.1016/0306-4522(91)90038-P McKim, 1980, The effects of caffeine, theophylline and amphetamine on operand responding of the mouse, Psychopharmacology, 68, 135, 10.1007/BF00432130 Michaelis, 1979, Adenosine modulation of synaptosomal dopamine release, Life Sci., 24, 2083, 10.1016/0024-3205(79)90082-1 Morgan, 1989, Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry, Life Sci., 45, 2025, 10.1016/0024-3205(89)90577-8 Mumford, 1991, Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat, J. Pharmac. exp. Ther., 258, 857 Myers, 1986, Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists, Brain Res., 375, 193, 10.1016/0006-8993(86)90975-3 Nakajima, 1989, Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain, Brain Res., 501, 307, 10.1016/0006-8993(89)90647-1 Nikodijeviç, 1990, Characterization of the locomotor depression produced by an A2-selective adenosine agonist, Fedn Euro. biochem. Socs Lett., 261, 67, 10.1016/0014-5793(90)80638-Y Onali, 1988, Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes, Brain Res., 456, 302, 10.1016/0006-8993(88)90232-6 Onali, 1985, Characterization of dopamine receptors mediating inhibition of adenylyl cyclase activity in rat striatum, Molec. Pharmac., 28, 138 Parkinson, 1990, Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand, Naunyn Schmiedeberg's Arch. Pharmac., 342, 85, 10.1007/BF00178977 Premont, 1979, Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution, Molec. Pharmac., 16, 790 Premont, 1979, Effects of adenosine on adenylate cyclase in broken cell preparations of central nervous system, 259 Rall, 1982, Evolution of the mechanisms of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors, Pharmacologist, 24, 277 Riberio, 1979, Adenosine and adenosine triphosphate decrease45Ca uptake by synaptosomes stimulated by potassium, Biochem. Pharmac., 28, 1297, 10.1016/0006-2952(79)90428-3 Sattin, 1970, The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′phosphate content of guinea pig cerebral cortex slices, Molec. Pharmac., 6, 13 Schiffmann, 1991, (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study, J. Neurochem., 57, 1062, 10.1111/j.1471-4159.1991.tb08257.x Snyder, 1981, Adenosine receptors and behavioural actions of methylxanthines, 78, 3260 Snyder, 1985, Adenosine as a neuromodulator, A. Rev. Neurosci., 8, 103, 10.1146/annurev.ne.08.030185.000535 Spealman, 1986, Behavioural effects of adenosine analogues in squirrel monkeys: relation to adenosine A2 receptors, Psychopharmacology, 95, 19 Spealman, 1988, Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism, Psychopharmacology, 95, 19, 10.1007/BF00212759 Thithapandha, 1972, Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations, 139, 582 Ungerstedt, 1971, Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigrostriatal dopamine system in the rat brain, Acta physiol. scand., 367, 69, 10.1111/j.1365-201X.1971.tb11000.x Ungerstedt, 1981, Behavioural pharmacology of dopamine receptor mechanisms, 481 Vallar, 1989, Mechanisms of signal transduction at dopamine D2 receptors, Trends pharmac. Sci., 10, 74, 10.1016/0165-6147(89)90082-5 Van Calker, 1979, Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells, J. Neurochem., 33, 999, 10.1111/j.1471-4159.1979.tb05236.x Vapaatalo, 1981, Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA), Drug Res., 25, 407 Waldeck, 1973, Sensitization by caffeine of central catecholamine receptors, J. neural Transm., 34, 61, 10.1007/BF01244827 Wamsley, 1992, CNS distribution of D1 receptors: use of a new specific D1 receptor antagonist [3H]SCH 39166, Neurochem. Int., 20, 123S, 10.1016/0197-0186(92)90224-F White, 1978, Monoamine synthesis and caffeine-induced locomotor activity, Neuropharmacology, 27, 511, 10.1016/0028-3908(78)90058-8 Winn, 1980, Brain adenosine production in rat during sustained-alteration in systemic blood pressure, Am. J. Physiol., 239, H636 Winn, 1981, Brain adenosine concentration during hypoxia in rats, Am. J. Physiol., 241, H235 Wood, 1989, Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation, Neuropharmacology, 28, 21, 10.1016/0028-3908(89)90062-2 Zetler, 1985, Neuropharmacological profile of cholecystokinin-like peptides, Ann. N.Y. Acad. Sci., 448, 448, 10.1111/j.1749-6632.1985.tb29940.x Zetterström, 1982, Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre, Neurosci. Lett., 29, 111, 10.1016/0304-3940(82)90338-X